Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Multiple Myeloma 107Precursor Cell Lymphoblastic Leukemia-Lymphoma 38Leukemia 23Lymphoma 20Recurrence 16Burkitt Lymphoma 16Lymphoma, Mantle-Cell 13Neoplasms, Plasma Cell 11Lymphoma, Non-Hodgkin 11Waldenstrom Macroglobulinemia 9Lymphoma, Follicular 9Immunoglobulin Light-chain Amyloidosis 9Hodgkin Disease 9Breast Neoplasms 9Vomiting 8Neoplasms 8Nausea 8Lymphoma, B-Cell, Marginal Zone 8Lymphoma, Large B-Cell, Diffuse 7Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6Lymphoma, T-Cell, Cutaneous 6Leukemia, Lymphocytic, Chronic, B-Cell 6Amyloidosis 6Leukemia, Myeloid, Acute 5Smoldering Multiple Myeloma 4Sezary Syndrome 4Mycosis Fungoides 4Lymphoma, Large-Cell, Immunoblastic 4Lung Neoplasms 4Blast Crisis 4

Interventions

Alemtuzumab 2tocilizumab 1Whole-Body Irradiation 1Polymerase Chain Reaction 1Methotrexate 1In Situ Hybridization 1Immunohistochemistry 1Flow Cytometry 1Etoposide 1Emapalumab 1Dexamethasone 1Data Collection 1Cytogenetic Analysis 1Cytarabine 1Cyclophosphamide 1Calcium Dobesilate 1Blotting, Western 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Lymphohistiocytosis, Hemophagocytic × Calcium Dobesilate × Clear all
NCT02385110 2024-01-17

Alemtuzumab or Tocilizumab in Combination With Etoposide and Dexamethasone for the Treatment of Adult Patients With Hemophagocytic Lymphohistiocytosis

M.D. Anderson Cancer Center

Phase 2 Completed
18 enrolled 10 charts
MyeloidOther hematologic neoplasm

Leukemia, Lymphohistiocytosis, Hemophagocytic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡